Zobrazeno 1 - 10 of 27 pro vyhledávání: '"Stacey C Fitzsimmons"'
1
Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population
Autor: James E. Haddow, Stacey C Fitzsimmons, Glenn E. Palomaki
Publikováno v: Genetics in Medicine. 6:405-414
Purpose: To estimate CFTR mutation frequencies, clinical sensitivities (proportions of carrier couples or affected fetuses detected), and birth prevalence estimates for broad racial/ethnic groups and for a panethnic U.S. population. Methods: Publishe
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2005798b96111ccb47f3cdc2d8a0f861
https://doi.org/10.1097/01.gim.0000139505.06194.39
Zobrazit plný text záznamu
2
The Association of Socioeconomic Status with Outcomes in Cystic Fibrosis Patients in the United States
Autor: Stacey C. Fitzsimmons, Peter A. Margolis, Michael S. Schechter, Brent J. Shelton
Publikováno v: American Journal of Respiratory and Critical Care Medicine. 163:1331-1337
There is considerable variability in the clinical course of disease in cystic fibrosis (CF). Although currently unidentified modifier genes might explain some of this heterogeneity, other factors are probably contributory. Socioeconomic status (SES)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daee110bbdfd0cd1c10f99d8d22820d7
https://doi.org/10.1164/ajrccm.163.6.9912100
Zobrazit plný text záznamu
3
Predictive 5-Year Survivorship Model of Cystic Fibrosis
Autor: Bruce C. Marshall, Theodore G. Liou, Jonathan R. Hibbs, Barbara C. Cahill, Frederick R. Adler, Stacey C. FitzSimmons
Publikováno v: American Journal of Epidemiology. 153:345-352
The objective of this study was to create a 5-year survivorship model to identify key clinical features of cystic fibrosis. Such a model could help researchers and clinicians to evaluate therapies, improve the design of prospective studies, monitor p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33b4c92247fc9a81460c05d66fa317af
https://doi.org/10.1093/aje/153.4.345
Zobrazit plný text záznamu
4
Risk of Persistent Growth Impairment after Alternate-Day Prednisone Treatment in Children with Cystic Fibrosis
Autor: Preston W. Campbell, HuiChuan J. Lai, Philip M. Farrell, Michael R. Kosorok, Stacey C. FitzSimmons, Beryl J. Rosenstein, David B. Allen
Publikováno v: New England Journal of Medicine. 342:851-859
It is uncertain whether the growth impairment that occurs in children during long-term treatment with glucocorticoids persists after the medication is discontinued and ultimately affects adult height.We evaluated growth six to seven years after alter
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65f064865fb201035126173eadfc6eda
https://doi.org/10.1056/nejm200003233421204
Zobrazit plný text záznamu
7
Comparison of growth status of patients with cystic fibrosis between the United States and Canada
Autor: HuiChuan J. Lai, Mary Corey, Philip M. Farrell, Stacey C. FitzSimmons, Michael R. Kosorok
Publikováno v: The American Journal of Clinical Nutrition. 69:531-538
Background: Differences in growth status of patients with cystic fibrosis (CF) between the United States and Canada were reported in the 1980s based on analysis of data from 2 regional CF centers. Objective: We evaluated the current growth status of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e245a60369b2b6f7f44efa1dfdbd12c
https://doi.org/10.1093/ajcn/69.3.531
Zobrazit plný text záznamu
8
Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: Evaluation of various criteria used to identify malnutrition
Autor: Sherie A. Sondel, Stacey C. FitzSimmons, Sarah Walker, Christopher G. Green, Guanghong Shen, Philip M. Farrell, HuiChuan J. Lai, Shu-Tien Chen, Michael R. Kosorok
Publikováno v: The Journal of Pediatrics. 132:478-485
The objectives of this study were to determine growth status and to identify malnutrition with various anthropometric indicators in children with cystic fibrosis (CF) based on cross-sectional analysis of the 1993 National CF Patient Registry data.Hei
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a0b424b4055625b01401e03866a578f
https://doi.org/10.1016/s0022-3476(98)70024-1
Zobrazit plný text záznamu
9
Comparison of the clinical manifestations of cystic fibrosis in black and white patients
Autor: Beryl J. Rosenstein, Stacey C. FitzSimmons, Ada Hamosh, Garry R. Cutting, Milan Macek, Michael R. Knowles
Publikováno v: The Journal of Pediatrics. 132:255-259
No large-scale studies of the incidence or disease severity of cystic fibrosis (CF) in black patients have been reported to date. In this study, the CF Foundation National Patient Registry was used to establish new incidence figures and to compare th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::571885b5d04f41b8cbe500b19233dc53
https://doi.org/10.1016/s0022-3476(98)70441-x
Zobrazit plný text záznamu
10
High-Dose Pancreatic-Enzyme Supplements and Fibrosing Colonopathy in Children with Cystic Fibrosis
Autor: Thomas Hammerstrom, Drucy Borowitz, John D. Lloyd-Still, Albert B. Lowenfels, Peter R. Durie, Stacey C. FitzSimmons, Richard J. Grand, Greg A. Burkhart
Publikováno v: New England Journal of Medicine. 336:1283-1289
Fibrosing colonopathy has been reported in young children with cystic fibrosis, the majority of whom take high-strength pancreatic-enzyme supplements to control intestinal malabsorption. We conducted a case-control study in the United States to inves
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d488a875b87d0112069aba5f26bade1b
https://doi.org/10.1056/nejm199705013361803
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje